Key terms
About NOTV
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NOTV news
May 06
9:08am ET
Inotiv (NOTV) Receives a Buy from Craig-Hallum
Apr 08
9:01am ET
Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Inotiv (NOTV)
Apr 04
9:39am ET
Inotiv trading resumes
Apr 04
9:34am ET
Inotiv trading halted, volatility trading pause
Mar 26
8:50am ET
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)
Mar 25
10:25am ET
Craig-Hallum Keeps Their Buy Rating on Inotiv (NOTV)
Mar 19
5:42pm ET
Inotiv Shareholders Elect Board Members, Ratify Auditor for 2024
Mar 01
9:01am ET
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), BioLife Solutions (BLFS) and Inotiv (NOTV)
Feb 28
1:50pm ET
Inotiv participates in a conference call with Lake Street
Feb 28
4:55am ET
Inotiv participates in a conference call with Lake Street
Feb 26
12:17pm ET
Inotiv participates in a conference call with Lake Street
Feb 09
4:58am ET
Inotiv upgraded to Buy from Hold at Jefferies
Feb 08
8:40am ET
Craig-Hallum remains bullish on Inotiv following solid start to new year
Feb 07
4:18pm ET
Inotiv sees FY24 revenue $$580M-$590M, consensus $578.14M
Feb 07
4:16pm ET
Inotiv reports Q1 EPS (60c), consensus (85c)
No recent press releases are available for NOTV
NOTV Financials
Key terms
Ad Feedback
NOTV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NOTV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range